[go: up one dir, main page]

WO1999054353A3 - Sequences d'acide nucleique humaines provenant du tissu normal de l'uterus - Google Patents

Sequences d'acide nucleique humaines provenant du tissu normal de l'uterus Download PDF

Info

Publication number
WO1999054353A3
WO1999054353A3 PCT/DE1999/001175 DE9901175W WO9954353A3 WO 1999054353 A3 WO1999054353 A3 WO 1999054353A3 DE 9901175 W DE9901175 W DE 9901175W WO 9954353 A3 WO9954353 A3 WO 9954353A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
acid sequences
human nucleic
normal uterus
uterus tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE1999/001175
Other languages
German (de)
English (en)
Other versions
WO1999054353A2 (fr
Inventor
Thomas Specht
Bernd Hinzmann
Armin Schmitt
Christian Pilarsky
Edgar Dahl
Andre Rosenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Original Assignee
METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH filed Critical METAGEN GESELLSCHAFT fur GENOMFORSCHUNG MBH
Priority to JP2000544691A priority Critical patent/JP2002512017A/ja
Priority to EP99924793A priority patent/EP1071777A2/fr
Publication of WO1999054353A2 publication Critical patent/WO1999054353A2/fr
Publication of WO1999054353A3 publication Critical patent/WO1999054353A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des séquences d'acide nucléique humaines (ARNm, ADNc, séquences génomiques) provenant du tissu normal de l'utérus, qui codent pour des produits géniques ou pour des parties desdits produits géniques, ainsi que leur utilisation. Elle concerne également les polypeptides codés par lesdites séquences et leur utilisation.
PCT/DE1999/001175 1998-04-17 1999-04-15 Sequences d'acide nucleique humaines provenant du tissu normal de l'uterus Ceased WO1999054353A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000544691A JP2002512017A (ja) 1998-04-17 1999-04-15 正常子宮組織からのヒト核酸配列
EP99924793A EP1071777A2 (fr) 1998-04-17 1999-04-15 Sequences d'acide nucleique humaines provenant du tissu normal de l'uterus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19817946.4 1998-04-17
DE19817946A DE19817946A1 (de) 1998-04-17 1998-04-17 Menschliche Nukleinsäuresequenzen aus Uterus-Normalgewebe

Publications (2)

Publication Number Publication Date
WO1999054353A2 WO1999054353A2 (fr) 1999-10-28
WO1999054353A3 true WO1999054353A3 (fr) 2000-07-20

Family

ID=7865424

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/001175 Ceased WO1999054353A2 (fr) 1998-04-17 1999-04-15 Sequences d'acide nucleique humaines provenant du tissu normal de l'uterus

Country Status (4)

Country Link
EP (1) EP1071777A2 (fr)
JP (1) JP2002512017A (fr)
DE (1) DE19817946A1 (fr)
WO (1) WO1999054353A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053754A1 (fr) * 1999-03-08 2000-09-14 Genentech, Inc. Compositions et methodes pour le traitement de tumeurs
US6372473B1 (en) 1997-05-28 2002-04-16 Human Genome Sciences, Inc. Tissue plasminogen activator-like protease
EP2050762A3 (fr) * 1998-03-10 2009-07-08 Genentech, Inc. Nouvelles polypeptides et acides nucléiques les codant
AU2002301608C1 (en) * 1998-03-10 2005-08-11 Genentech, Inc. Novel PRO351 Polypeptides and Nucleic Acids Encoding Same
US7723488B2 (en) 1998-03-27 2010-05-25 Genentech, Inc. Monoclonal antibodies to secreted and transmembrane polypeptides
DE69939989D1 (de) * 1998-04-22 2009-01-08 Genentech Inc Menschliches gas-6 (growth arrest-specific gene 6) Protein und dafür kodierende Nukleinsäuren
JP2004500045A (ja) * 1999-10-18 2004-01-08 レキシコン・ジェネティクス・インコーポレーテッド 新規ヒトタンパクおよびそれをコードするポリヌクレオチド
AU1174501A (en) * 1999-11-10 2001-06-06 Compugen Ltd. Chordin-like homologs
AU2001241968B2 (en) * 2000-03-02 2005-09-15 Amgen Inc. Chordin-like-2 molecules and uses thereof
DE60109922D1 (de) 2000-05-31 2005-05-12 Genzyme Corp Therapeutische verbindungen gegen eierstockkrebs
WO2002029086A2 (fr) * 2000-10-02 2002-04-11 Bayer Corporation Sequences d'acide nucleique differentiellement exprimees dans un tissu cancereux
AU2002232563A1 (en) * 2001-12-05 2003-06-23 Genzyme Corporation Compounds for therapy and diagnosis and methods for using same
GB0216727D0 (en) 2002-07-17 2002-08-28 Univ Cambridge Tech Genes
BRPI0509420A (pt) 2004-04-14 2007-09-04 Genentech Inc método de redução ou inibição da angiogênese e método de aumento da eficácia de tratamento com agente antiangiogênico
MX2011010570A (es) 2009-05-08 2011-10-19 Genentech Inc Anticuerpos anti-egfl7 humanizados y metodos de uso de los mismos.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024655A1 (fr) * 1992-05-27 1993-12-09 Amersham International Plc Analyse d'arn
WO1999055858A2 (fr) * 1998-04-28 1999-11-04 Metagen Gesellschaft Für Genomforschung Mbh Sequences nucleotidiques humaines obtenues a partir d'un tissu tumoral du pancreas

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024655A1 (fr) * 1992-05-27 1993-12-09 Amersham International Plc Analyse d'arn
WO1999055858A2 (fr) * 1998-04-28 1999-11-04 Metagen Gesellschaft Für Genomforschung Mbh Sequences nucleotidiques humaines obtenues a partir d'un tissu tumoral du pancreas

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BONFIELD, J. ET AL.: "A new sequence assembly program", NUCLEIC ACIDS RESEARCH., vol. 23, 1995, pages 4992-9, XP002127627, ISSN: 0305-1048 *
CRESCENZI, E., ET AL.: "identification of differentially expressed mRNAs in normal and neoplastiic (adenocarcinoma) human endometrium", GYNECOLOGIC ONCOLOGY, vol. 63, November 1996 (1996-11-01), pages 228 - 233, XP000874036 *
FANNON M R: "Gene expression in normal and disease states - identification of therapeutic targets", TRENDS IN BIOTECHNOLOGY,GB,ELSEVIER PUBLICATIONS, CAMBRIDGE, vol. 14, no. 8, 1 August 1996 (1996-08-01), pages 294 - 298, XP004035748, ISSN: 0167-7799 *
HILLIER, L., ET AL.: "the WashU-Merck EST project - unpublished", EMBL SEQUENCE DATA LIBRARY, 7 September 1996 (1996-09-07), heidelberg, germany, XP002129529 *
HILLIER, L., ET AL.: "the WashU-Merck EST project 1997", EMBL SEQUENCE DATA LIBRARY, 11 June 1997 (1997-06-11), heidelberg, germany, XP002129531 *
HILLIER, L., ET AL.: "the WashU-Merck EST project 1997", EMBL SEQUENCE DATA LIBRARY, 14 May 1997 (1997-05-14), heidelberg, germany, XP002129530 *
JANSA,P., ET AL.: "cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes", THE EMBO JOURNAL, vol. 17, no. 10, 15 May 1998 (1998-05-15), pages 2855 - 2864, XP002129532 *
SCHMITT AO. ET AL.: "Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues.", NUCLEIC ACID RESEARCH, vol. 27, no. 21, November 1999 (1999-11-01), pages 4251 - 4260, XP002129533 *
SCHULER, G. D.: "Sequence mapping by electronic PCR", GENOME RESEARCH., vol. 7, 1997, pages 541 - 550, XP002127628, ISSN: 1088-9051 *
WANG, Y. AND MIKSICEK, R.J.: "characterization of estrogen receptor cDNAs of human uterus: identification of a novel PvuII polymorphism", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 101, 1994, pages 101 - 110, XP000874034 *

Also Published As

Publication number Publication date
WO1999054353A2 (fr) 1999-10-28
EP1071777A2 (fr) 2001-01-31
DE19817946A1 (de) 1999-10-21
JP2002512017A (ja) 2002-04-23

Similar Documents

Publication Publication Date Title
WO1999054461A3 (fr) Sequences d'acide nucleique humaines provenant d'une tumeur de l'endometre
WO1999047669A3 (fr) Sequences d'acide nucleique humain tirees de tissus de tumeurs du sein
WO1999053051A3 (fr) Etiquettes de sequences exprimees (est) des 5' et proteines humaines codees
WO1999054460A3 (fr) Sequences d'acide nucleique provenant du tissu normal de la vessie
WO1999051727A3 (fr) Sequences d'acides nucleiques humaines extraites des tissus sains d'ovaires
WO1999055858A3 (fr) Sequences nucleotidiques humaines obtenues a partir d'un tissu tumoral du pancreas
WO1999054353A3 (fr) Sequences d'acide nucleique humaines provenant du tissu normal de l'uterus
CA2296769A1 (fr) Facteur modifie affectant le tissu dorsal et composition a base de ce facteur
WO1999006548A3 (fr) Est 5' pour proteines secretees sans specificite tissulaire
EP1033401A3 (fr) Marqueurs de séquence exprimées et protéines humaines codées
WO2002002624A3 (fr) Molecules de type b7 et utilisation de ces molecules
WO2002024891A3 (fr) Molecules semblables a b7 (b7-like, b7-l) et utilisations correspondantes
WO1999006554A3 (fr) Est 5' pour proteines secretees exprimees dans des tissus musculaires et autres tissus mesodermiques
ZA200007040B (en) Catalyst modifiers and their use in the polymerization of olefin(s).
WO1999006549A3 (fr) Est 5' pour proteines exprimees dans les testicules et autres tissus
WO1999040189A3 (fr) ADNc CODANT DES PROTEINES SECRETEES
WO2001047944A3 (fr) Acides nucleiques contenant des polymorphismes mononucleotidiques et procedes d'utilisation correspondants
WO2001070977A3 (fr) Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations
WO2001068854A3 (fr) Molecules s'apparentant au facteur de croissance des fibroblastes et leurs utilisations
WO1999006439A3 (fr) Est 5' pour proteines secretees exprimees dans l'endoderme
WO1999006553A3 (fr) Est 5' pour proteines secretees exprimees dans divers tissus
WO1999054447A3 (fr) Sequences d'acide nucleique provenant de tissus tumoraux de la vessie
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
WO2000029623A3 (fr) Acides nucleiques contenant des polymorphismes d'un seul nucleotide et utilisations de ces acides nucleiques
WO1999047655A3 (fr) Sequences d'acides nucleiques humains provenant de tissus mammaires sains

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1999924793

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09647788

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1999924793

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999924793

Country of ref document: EP